Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Health Policy OPEN
|
June 29, 2023
The impact of external reference pricing on pharmaceutical costs and market dynamics
Dominic Voehler, Benjamin C Koethe, Patricia G Synnott, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 15, 2025
Characterizing financial risk from out-of-pocket expenditures across dementia stages
Patricia G Synnott, Yingying Zhu, Angie Mae Rodday, et al.
BMJ Global Health
|
June 8, 2021
Bridging the gap: aligning economic research with disease burden
Lauren A Do, Patricia G Synnott, Siyu Ma, et al.
Applied Health Economics and Health Policy
|
December 18, 2022
The Value of New: Consideration of Product Novelty in Health Technology Assessments of Pharmaceuticals
Patricia G Synnott, Dominic Voehler, Daniel E Enright, et al.
Journal of Managed Care & Specialty Pharmacy
|
February 28, 2020
The Effectiveness and Value of Siponimod for Secondary Progressive Multiple Sclerosis
Patricia G Synnott, Lisa M Bloudek, Ravi Sharaf, et al.
International Journal of Technology Assessment in Health Care
|
April 21, 2022
Is Value Portable? An Examination of Contextual and Practical Considerations that Affect the Transferability of Value Assessments between Settings
Patricia G Synnott, Pei-Jung Lin, Stacey S Hickson, et al.
Journal of Managed Care & Specialty Pharmacy
|
May 29, 2020
The Effectiveness and Value of Rivaroxaban and Icosapent Ethyl as Additive Therapies for Cardiovascular Disease
Patricia G Synnott, R Brett McQueen, Daniel A Ollendorf, et al.
JAMA Network Open
|
October 31, 2024
Modeling the Population Equity of Alzheimer Disease Treatments in the US
Patricia G Synnott, Thomas Majda, Pei-Jung Lin, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2021
The effectiveness and value of aducanumab for Alzheimer's disease
Patricia G Synnott, Melanie D Whittington, Grace A Lin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 28, 2016
Evaluating the Importance of Heterogeneity of Treatment Effect: Variation in Patient Utilities Can Influence Choice of the "Optimal" Oral Anticoagulant for Atrial Fibrillation
Christopher G Cameron, Patricia G Synnott, Steven D Pearson, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Health Policy OPEN
|
June 29, 2023
The impact of external reference pricing on pharmaceutical costs and market dynamics
Dominic Voehler, Benjamin C Koethe, Patricia G Synnott, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 15, 2025
Characterizing financial risk from out-of-pocket expenditures across dementia stages
Patricia G Synnott, Yingying Zhu, Angie Mae Rodday, et al.
BMJ Global Health
|
June 8, 2021
Bridging the gap: aligning economic research with disease burden
Lauren A Do, Patricia G Synnott, Siyu Ma, et al.
Applied Health Economics and Health Policy
|
December 18, 2022
The Value of New: Consideration of Product Novelty in Health Technology Assessments of Pharmaceuticals
Patricia G Synnott, Dominic Voehler, Daniel E Enright, et al.
Journal of Managed Care & Specialty Pharmacy
|
February 28, 2020
The Effectiveness and Value of Siponimod for Secondary Progressive Multiple Sclerosis
Patricia G Synnott, Lisa M Bloudek, Ravi Sharaf, et al.
International Journal of Technology Assessment in Health Care
|
April 21, 2022
Is Value Portable? An Examination of Contextual and Practical Considerations that Affect the Transferability of Value Assessments between Settings
Patricia G Synnott, Pei-Jung Lin, Stacey S Hickson, et al.
Journal of Managed Care & Specialty Pharmacy
|
May 29, 2020
The Effectiveness and Value of Rivaroxaban and Icosapent Ethyl as Additive Therapies for Cardiovascular Disease
Patricia G Synnott, R Brett McQueen, Daniel A Ollendorf, et al.
JAMA Network Open
|
October 31, 2024
Modeling the Population Equity of Alzheimer Disease Treatments in the US
Patricia G Synnott, Thomas Majda, Pei-Jung Lin, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2021
The effectiveness and value of aducanumab for Alzheimer's disease
Patricia G Synnott, Melanie D Whittington, Grace A Lin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 28, 2016
Evaluating the Importance of Heterogeneity of Treatment Effect: Variation in Patient Utilities Can Influence Choice of the "Optimal" Oral Anticoagulant for Atrial Fibrillation
Christopher G Cameron, Patricia G Synnott, Steven D Pearson, et al.
Page
of 3